Functional Medicine for Mental Health

What is functional medicine for mental health?

Functional medicine for mental health treats mood and anxiety as dysfunction in the limbic system, not as one missing neurotransmitter. It evaluates the physiology feeding the brain: blood sugar, stress resiliency, inflammation, the gut, hormones, circulation, and past brain injury. Depression reflects reduced activation of the prefrontal cortex, and anxiety reflects an overactive amygdala, with many possible drivers behind each. The clinician finds the drivers in the individual patient and works to restore function, rather than suppressing a symptom.

How does functional medicine treat mood and anxiety disorders?

Mood has been treated as a single neurotransmitter running low, so care stops at serotonin and dopamine support and never asks why those pathways are failing. That model leaves a large group of chronic patients symptomatic after every antidepressant has been tried. This course teaches a different starting point: a mood disorder means something in the limbic system is not working, and the clinician's job is to find the physiology pushing on it.

Why don't antidepressants fix chronic depression?

The antidepressant literature is among the most selectively reported in all of medicine. Placebo accounts for a large share of the early response, and in one imaging study the placebo lit up the brain's own opioid system as strongly as the drug. Across the trials submitted for approval, roughly half showed no benefit, yet almost all of the positive studies reached print while the negative ones did not.

Long-term data is worse. Large reviews find no reliable evidence that staying on an antidepressant for years improves quality of life, and a sizable group reports emotional numbing, weight gain, and sexual side effects instead.

The research has moved on. Chronic, treatment-resistant depression is now understood as a problem of plasticity, meaning an unhealthy brain. That is why ketamine helps some severe cases: it raises BDNF and restores neuron signaling, not just neurotransmitter levels. The clinical lesson is to stop treating a long-standing mood disorder as a nutrient shortage and start treating the brain itself.

What does it mean to treat mood as limbic system dysfunction?

The limbic system has a structure, and dysfunction can enter at any level of it. There are regions, such as the prefrontal cortex and the amygdala. There are circuits that connect those regions. There are the cells inside them, the neurons, microglia, and astrocytes. And there are the cellular functions those cells perform, such as the synapse, blood-brain barrier integrity, and circulation.

A simple place to begin: depression is reduced activation of the prefrontal cortex, anxiety is increased activation of the amygdala, and bipolar disorder is immune activation of damaged limbic networks. This is why there is no single protocol for a diagnosis. Two patients with the same label can have very different lesions, one inflammatory, one vascular, one neurodegenerative.

The neurotransmitters still matter, but mostly as clues. A patient who cannot start or finish anything points you toward dopamine. A patient who feels no joy in things they used to love points toward serotonin. The symptom pattern tells you which circuit to examine.

What is the physiological web behind a mood disorder?

Real patients never arrive with one problem. They bring depression plus bloating plus fatigue plus pain, and the skill is knowing where to pull. Dr. Kharrazian maps the drivers as a web whose threads feed each other and the limbic system: blood sugar, stress physiology, inflammation, the microbiome, and hormones.

Blood sugar sits at the center. Serotonin, dopamine, and the catecholamines all depend on the ratio of insulin to branched-chain amino acids that carries their precursors across the blood-brain barrier. Every hypoglycemic swing and every insulin surge disrupts that ratio, so neurotransmitter synthesis falters across the board. Stabilize blood sugar, or the mood work will not hold.

Stress belongs on the same web, through the idea of resiliency. When resiliency drops, the stress response disrupts the gut, and intestinal permeability with endotoxemia sends bacterial lipopolysaccharide into circulation, where it inflames the brain. Hormones close the loop, because thyroid, estrogen, progesterone, and testosterone each modulate neurotransmitter activity. Pull on any thread and you move the others, which is how one well-chosen intervention can change a case that nine supplements could not.

How do you tell neurological anxiety from metabolic anxiety?

Some anxiety is driven by the brain's wiring, not its chemistry, and the physical exam separates the two quickly. A sensitized amygdala fires on small amounts of catecholamine. A failing basal ganglia can no longer dampen the amygdala. And a cerebellum injured by gluten ataxia or alcohol cannot process vestibular signals, so the brain feels like it is falling all day and runs the fear response to match.

A brief in-office balance and gaze check tells you which you are dealing with. When anxiety and vertigo arrive together on cue, the chronic anxiety disorder is often cerebellar, and the workup turns to celiac disease and cerebellar autoimmunity rather than another anxiolytic.

Where do you start with a complex patient?

Sequencing is the hardest part of chronic care, and the course is direct about it. Do not default to the gut, and do not default to hormones. Start with the three pillars that move the whole web: movement, sleep, and blood sugar. Exercise is the single most powerful lever, because intensity raises BDNF and no supplement does that on its own.

From there the work is phased against the patient's critical load. Most mood disorders are not one mechanism but several stacked until the system tips. So you name the drivers, calm inflammation and blood sugar first, add movement as the patient can tolerate it, and sequence deeper work later, with scheduled reevaluation. Nutraceuticals have a place, chosen by mechanism and by the strongest evidence, but they support the plan rather than carry it.

For related reading, see Primary Hypothyroidism vs. Pituitary Fatigue: Reading the Blood Chemistry, Treating a Pathology vs. Managing Systemic Dysfunction: What's the Difference?, Beyond Pharmaceuticals: Integrative Migraine Management, and Metabolic Dysfunction as Hidden Driver of Chronic Migraines.